Schrag SJ - Search Results

1

Intrapartum antibiotic prophylaxis for the prevention of perinatal group B streptococcal disease: experience in the United States and implications for a potential group B streptococcal vaccine.

Schrag SJ, Verani JR. Schrag SJ, et al. Vaccine. 2013 Aug 28;31 Suppl 4:D20-6. doi: 10.1016/j.vaccine.2012.11.056. Epub 2012 Dec 3. Vaccine. 2013. PMID: 23219695 Review.

2

Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis.

Schrag SJ, Zywicki S, Farley MM, Reingold AL, Harrison LH, Lefkowitz LB, Hadler JL, Danila R, Cieslak PR, Schuchat A. Schrag SJ, et al. N Engl J Med. 2000 Jan 6;342(1):15-20. doi: 10.1056/NEJM200001063420103. N Engl J Med. 2000. PMID: 10620644

3

Neonatal group B streptococcal disease: how infection control teams can contribute to prevention efforts.

Schrag SJ, Whitney CG, Schuchat A. Schrag SJ, et al. Infect Control Hosp Epidemiol. 2000 Jul;21(7):473-83. doi: 10.1086/501791. Infect Control Hosp Epidemiol. 2000. PMID: 10926399 Review.

4

Limiting the spread of resistant pneumococci: biological and epidemiologic evidence for the effectiveness of alternative interventions.

Schrag SJ, Beall B, Dowell SF. Schrag SJ, et al. Clin Microbiol Rev. 2000 Oct;13(4):588-601. doi: 10.1128/CMR.13.4.588. Clin Microbiol Rev. 2000. PMID: 11023959 Free PMC article. Review.

5

Effect of short-course, high-dose amoxicillin therapy on resistant pneumococcal carriage: a randomized trial.

Schrag SJ, Peña C, Fernández J, Sánchez J, Gómez V, Pérez E, Feris JM, Besser RE. Schrag SJ, et al. JAMA. 2001 Jul 4;286(1):49-56. doi: 10.1001/jama.286.1.49. JAMA. 2001. PMID: 11434826 Clinical Trial.

6

Early opportunities for prevention: infections of pregnant women and young infants.

Schuchat A, Hillier S, Edwards K, Schrag S, Labbok M. Schuchat A, et al. Emerg Infect Dis. 2001;7(3 Suppl):532. doi: 10.3201/eid0707.017711. Emerg Infect Dis. 2001. PMID: 11485649 Free PMC article. No abstract available.

7

Sentinel surveillance: a reliable way to track antibiotic resistance in communities?

Schrag SJ, Zell ER, Schuchat A, Whitney CG. Schrag SJ, et al. Emerg Infect Dis. 2002 May;8(5):496-502. doi: 10.3201/eid0805.010268. Emerg Infect Dis. 2002. PMID: 11996685 Free PMC article.

8

A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates.

Schrag SJ, Zell ER, Lynfield R, Roome A, Arnold KE, Craig AS, Harrison LH, Reingold A, Stefonek K, Smith G, Gamble M, Schuchat A; Active Bacterial Core Surveillance Team. Schrag SJ, et al. N Engl J Med. 2002 Jul 25;347(4):233-9. doi: 10.1056/NEJMoa020205. N Engl J Med. 2002. PMID: 12140298

9

Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC.

Schrag S, Gorwitz R, Fultz-Butts K, Schuchat A. Schrag S, et al. MMWR Recomm Rep. 2002 Aug 16;51(RR-11):1-22. MMWR Recomm Rep. 2002. PMID: 12211284

10

Effects of intrapartum antimicrobial prophylaxis for prevention of group-B-streptococcal disease on the incidence and ecology of early-onset neonatal sepsis.

Moore MR, Schrag SJ, Schuchat A. Moore MR, et al. Among authors: schrag sj. Lancet Infect Dis. 2003 Apr;3(4):201-13. doi: 10.1016/s1473-3099(03)00577-2. Lancet Infect Dis. 2003. PMID: 12679263 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results